相似文献
1
Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae.
Virulence. 2017 May 19;8(4):383-390. doi: 10.1080/21505594.2016.1188234. Epub 2016 May 17.
2
Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01440-17. Print 2017 Dec.
3
The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel.
Clin Infect Dis. 2017 Nov 29;65(12):2144-2149. doi: 10.1093/cid/cix615.
4
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Expert Rev Anti Infect Ther. 2016;14(1):95-108. doi: 10.1586/14787210.2016.1106940. Epub 2015 Nov 4.
5
[Clinical characteristics of carbapenem-resistant infection in pediatric liver transplantation recipients].
Zhonghua Er Ke Za Zhi. 2020 Aug 2;58(8):640-645. doi: 10.3760/cma.j.cn112140-20200316-00239.
6
Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.
Antimicrob Resist Infect Control. 2020 Jan 3;9(1):2. doi: 10.1186/s13756-019-0639-7. eCollection 2020.
7
Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.
Virulence. 2017 May 19;8(4):427-439. doi: 10.1080/21505594.2016.1185577. Epub 2016 May 11.
8
Characterisation of carbapenem-resistant Enterobacteriaceae from the southwestern Ohio, northern Kentucky and southeastern Indiana region.
J Glob Antimicrob Resist. 2016 Dec;7:141-144. doi: 10.1016/j.jgar.2016.08.012. Epub 2016 Oct 19.
9
Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.
Int J Antimicrob Agents. 2017 Jun;49(6):770-773. doi: 10.1016/j.ijantimicag.2017.01.018. Epub 2017 Apr 4.
10
High rate of colistin and fosfomycin resistance among carbapenemase-producing Enterobacteriaceae in Turkey.
Acta Microbiol Immunol Hung. 2019 Mar 1;66(1):103-112. doi: 10.1556/030.65.2018.042. Epub 2018 Nov 7.
引用本文的文献
1
Rectal screening for carbapenemase-producing Enterobacteriaceae in an intensive care unit in India.
Ghana Med J. 2024 Jun;58(2):156-164. doi: 10.4314/gmj.v58i2.7.
2
The impact of hospital-specific guidelines on carbapenem use and patient outcomes in a setting for high endemicity with multidrug-resistant gram-negative bacilli.
Antimicrob Steward Healthc Epidemiol. 2024 Sep 25;4(1):e146. doi: 10.1017/ash.2024.415. eCollection 2024.
3
Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Infections in a High-Endemic Hospital.
Antibiotics (Basel). 2024 Aug 23;13(9):792. doi: 10.3390/antibiotics13090792.
4
Comparison of the inoculum effect of in vitro antibacterial activity of Imipenem/relebactam and Ceftazidime/avibactam against ESBL-, KPC- and AmpC-producing Escherichia coli and Klebsiella pneumoniae.
Ann Clin Microbiol Antimicrob. 2023 Dec 10;22(1):107. doi: 10.1186/s12941-023-00660-5.
5
Descriptive analysis of infections due to New Delhi metallo-β-lactamase-producing Enterobacterales in children at Red Cross War Memorial Children's Hospital.
S Afr J Infect Dis. 2022 Jul 27;37(1):440. doi: 10.4102/sajid.v37i1.440. eCollection 2022.
6
Applying Diagnostic Stewardship to Proactively Optimize the Management of Urinary Tract Infections.
Antibiotics (Basel). 2022 Feb 24;11(3):308. doi: 10.3390/antibiotics11030308.
7
Effects of Regulation on Carbapenem Prescription in a Large Teaching Hospital in China: An Interrupted Time Series Analysis, 2016-2018.
Infect Drug Resist. 2021 Aug 11;14:3099-3108. doi: 10.2147/IDR.S322938. eCollection 2021.
8
Implementation of an antimicrobial stewardship programme and reduction in carbapenemase-producing Enterobacterales in an Australian local health district.
JAC Antimicrob Resist. 2020 Jul 13;2(3):dlaa041. doi: 10.1093/jacamr/dlaa041. eCollection 2020 Sep.
9
Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis.
Antibiotics (Basel). 2021 May 16;10(5):586. doi: 10.3390/antibiotics10050586.
10
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship.
Drugs. 2019 May;79(7):705-714. doi: 10.1007/s40265-019-01112-1.
本文引用的文献
1
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.
Clin Infect Dis. 2016 May 15;62(10):e51-77. doi: 10.1093/cid/ciw118. Epub 2016 Apr 13.
2
Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials.
Antibiotics (Basel). 2016 Jan 14;5(1):6. doi: 10.3390/antibiotics5010006.
3
New Societal Approaches to Empowering Antibiotic Stewardship.
JAMA. 2016;315(12):1229-30. doi: 10.1001/jama.2016.1346.
4
Clinicians' Attitudes Towards an Antimicrobial Stewardship Program at a Children's Hospital.
J Pediatric Infect Dis Soc. 2012 Sep;1(3):190-7. doi: 10.1093/jpids/pis045. Epub 2012 Jun 29.
5
Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison.
J Microbiol Immunol Infect. 2016 Feb;49(1):74-82. doi: 10.1016/j.jmii.2015.05.011. Epub 2015 Jun 27.
6
Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae.
PLoS Pathog. 2015 Sep 3;11(9):e1005132. doi: 10.1371/journal.ppat.1005132. eCollection 2015 Sep.
7
Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection.
JAMA Intern Med. 2015 Apr;175(4):626-33. doi: 10.1001/jamainternmed.2014.8273.
8
Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention.
Clin Infect Dis. 2014 Oct 15;59 Suppl 3(Suppl 3):S97-100. doi: 10.1093/cid/ciu542.
9
Review of rapid diagnostic tests used by antimicrobial stewardship programs.
Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S134-45. doi: 10.1093/cid/ciu547.
10
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients.
Cleve Clin J Med. 2013 Apr;80(4):225-33. doi: 10.3949/ccjm.80a.12182.
Zotero 插件